神马电影717,中文字幕在线观看国产,最全精品自拍视频在线,天天摸天天爽天天澡视频

首頁 /藥靶模型 /激酶靶點(diǎn) /EGFR /EGFR L858R-T790M-C797S/BaF3_Discontinue

EGFR L858R-T790M-C797S/BaF3_Discontinue

CBP73049

詢 價
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫

I. Introduction

Cell Line Name:

EGFR L858R-T790M-C797S/BaF3

Host Cell:

Ba/F3

Stability: 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

 
II. Background

EGFR is widely recognized for its importance in cancer. Amplification and mutations have been shown to be driving events in many cancer types. Its role in non-small cell lung cancer, glioblastoma and basal-like breast cancers has spurred many research and drug development efforts. Tyrosine kinase inhibitors have shown efficacy in EGFR amplfied tumors, most notably gefitinib and erlotinib. Mutations in EGFR have been shown to confer resistance to these drugs, particularly the variant T790M, which has been functionally characterized as a resistance marker for both of these drugs. The later generation TKI's have seen some success in treating these resistant cases, and targeted sequencing of the EGFR locus has become a common practice in treatment of non-small cell lung cancer. Overproduction of ligands is another possible mechanism of activation of EGFR. ERBB ligands include EGF, TGF-a, AREG, EPG, BTC, HB-EGF, EPR and NRG1-4 (for detailed information please refer to the respective ligand section). In ligand-activated cancers, Cetuximab appears to be more effective than tyrosine-kinase inhibitors.

 
III. Representative Data

1. WB of EGFR-L858R/T790M/C797S expression

Figure 1. WB of EGFR Expression
Lane 1: Negative control
Lane 2: EGFR-WT
Lane 3: EGFR-L858R/T790M
Lane 4: EGFR-L858R/T790M/C797S

2. Sanger sequencing

Figure 2. Sanger Sequencing of EGFR-L858R/T790M/C797S

3. Anti-proliferation assay

Figure 3. Anti-proliferation assay of three reference compounds on the EGFR L858R-T790M-C797S/BaF3 Stable Cell Line.


客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理(上海):18240630236 華東銷售經(jīng)理(上海、江蘇、安徽):15715191010 華北銷售經(jīng)理:18628311252 華南銷售經(jīng)理:13823536064 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13816461235
診斷標(biāo)準(zhǔn)品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18628311252 華南銷售經(jīng)理:13823536064 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13816461235

掃二維碼

立即提交
岚皋县| 洛隆县| 宿迁市| 陇川县| 扶风县| 商河县| 两当县| 玉田县| 清远市| 牟定县| 南和县| 桓仁| 高邑县| 明星| 英吉沙县| 竹山县| 驻马店市| 罗山县| 景德镇市| 长兴县| 桦川县| 昌平区| 探索| 瓦房店市| 宁强县| 漾濞| 兴义市| 石首市| 深州市| 丰宁| 台江县| 许昌市| 肇东市| 麦盖提县| 濮阳县| 闵行区| 汉阴县| 兴国县| 丰镇市| 双桥区| 台安县|